After Pfizer Inc announced Wednesday that the Covid vaccine it developed with BioNTech showed 95% efficacy in phase 3 final trial, BioNTech Chief Executive Officer, Ugur Sahin, told Reuters that vaccine deliveries could start before Christmas.
Key Quotes
“If all goes well I could imagine that we gain approval in the second half of December and start deliveries before Christmas, but really only if all goes positively.”
“US emergency use authorization (EUA) would be applied for on Friday.”
Market Reaction
S&P 500 futures have shrugged-off the upbeat comments, as fears over the surging COVID cases intensify and dent the appetite for riskier assets. The futures tied to the S&P 500 index drop 0.10% to 3,561, as of writing.
Reprinted from FX Street. The copyright is reserved by the original author.
면책 조항: 본 게시글에 표현된 견해는 전적으로 작성자의 견해이며 Followme의 공식 입장을 대변하지 않습니다. Followme는 제공된 정보의 정확성, 완전성 또는 신뢰성에 대해 책임을 지지 않으며, 서면으로 명시적으로 언급되지 않는 한 해당 내용을 기반으로 취해진 어떠한 조치에 대해서도 책임을 지지 않습니다.
더 오래된 의견은 없습니다. 소파를 가장 먼저 잡으십시오.